An observational, multicenter, retrospective, Italian Sarcoma Group (ISG) study of trabectedin in patients with advanced soft tissue sarcoma (STS)

Authors :: Giovanni Grignani
Angela Buonadonna
Giuseppe Badalamenti
Emanuela Marchesi
Antonio Pizzorusso
Elisabetta Setola
Emanuela Palmerini
Tommaso De Pas
Alessandro Comandone
Irene Quattrini
Antonella Brunello
Paolo G. Casali
Piero Picci
Toni Ibrahim
Stefano Ferrari
Virginia Ferraresi
Laura Milesi
Bruno Vincenzi
Federica Grosso
Gabriele Luppi
Source :: Journal of Clinical Oncology. 36:e23502-e23502
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: e23502Background: Trabectedin (T) is approved for patients (pts) with STS after failure of anthracyclines (A) and ifosfamide (I), or pts unsuited to receive AI. ISG performed a retrospective study ...

Tools